ZIC2
Basic information
Region (hg38): 13:99981784-99986765
Links
Phenotypes
GenCC
Source:
- holoprosencephaly 5 (Definitive), mode of inheritance: AD
- holoprosencephaly 5 (Strong), mode of inheritance: AD
- holoprosencephaly 5 (Strong), mode of inheritance: AD
- holoprosencephaly (Supportive), mode of inheritance: AR
- holoprosencephaly 5 (Definitive), mode of inheritance: AD
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Holoprosencephaly 5 | AD | General | Individuals with holoprosencephaly may demonstrate endocrine anomalies, including diabetes insipidus; Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Endocrine; Neurologic | 9771712; 11285244; 19955556; 20104608 |
ClinVar
This is a list of variants' phenotypes submitted to
- Holoprosencephaly 5 (16 variants)
- not provided (4 variants)
- Abnormality of the nervous system (1 variants)
- Inborn genetic diseases (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ZIC2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 105 | 114 | ||||
missense | 118 | 126 | ||||
nonsense | 4 | |||||
start loss | 2 | |||||
frameshift | 14 | 19 | ||||
inframe indel | 47 | 54 | ||||
splice donor/acceptor (+/-2bp) | 2 | |||||
splice region | 3 | 3 | 6 | |||
non coding | 12 | 23 | ||||
Total | 22 | 13 | 171 | 121 | 17 |
Variants in ZIC2
This is a list of pathogenic ClinVar variants found in the ZIC2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
13-99982046-G-C | Uncertain significance (Aug 04, 2017) | |||
13-99982065-A-T | Holoprosencephaly 5 | Uncertain significance (Dec 04, 2021) | ||
13-99982066-T-C | Holoprosencephaly 5 | Uncertain significance (Aug 17, 2023) | ||
13-99982070-C-T | Holoprosencephaly 5 | Likely benign (Oct 27, 2022) | ||
13-99982078-C-T | Holoprosencephaly 5 | Uncertain significance (Aug 16, 2022) | ||
13-99982086-C-T | Likely pathogenic (Mar 18, 2019) | |||
13-99982091-C-T | Holoprosencephaly 5 | Likely benign (May 07, 2022) | ||
13-99982101-G-C | Uncertain significance (Jul 19, 2017) | |||
13-99982103-G-A | Likely benign (Apr 16, 2018) | |||
13-99982105-T-C | Holoprosencephaly 5 | Uncertain significance (Dec 02, 2021) | ||
13-99982107-G-A | Inborn genetic diseases | Uncertain significance (Apr 07, 2023) | ||
13-99982111-G-A | ZIC2-related disorder | Uncertain significance (Mar 12, 2023) | ||
13-99982115-C-T | ZIC2-related disorder | Likely benign (May 01, 2019) | ||
13-99982116-G-C | Holoprosencephaly 5 | Uncertain significance (Jun 27, 2022) | ||
13-99982118-G-T | Holoprosencephaly 5 | Likely benign (Oct 19, 2022) | ||
13-99982121-C-T | Holoprosencephaly 5 | Likely benign (May 09, 2022) | ||
13-99982139-CGCGGCGGCG-C | Holoprosencephaly 5 | Uncertain significance (Jul 27, 2021) | ||
13-99982139-C-CGCG | Holoprosencephaly 5 | Uncertain significance (Jun 30, 2023) | ||
13-99982141-C-G | Inborn genetic diseases • Holoprosencephaly 5 | Uncertain significance (Oct 13, 2023) | ||
13-99982144-C-T | Holoprosencephaly 5 | Uncertain significance (Sep 04, 2023) | ||
13-99982147-C-G | Inborn genetic diseases | Uncertain significance (Jun 11, 2021) | ||
13-99982147-C-CGGGGGG | Inborn genetic diseases | Uncertain significance (Mar 24, 2021) | ||
13-99982147-C-CGGGGGGGGG | Inborn genetic diseases | Uncertain significance (Jul 08, 2021) | ||
13-99982147-C-CGGGGGGGGGG | Inborn genetic diseases | Pathogenic (Dec 15, 2021) | ||
13-99982150-C-G | Inborn genetic diseases | Uncertain significance (Jul 08, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ZIC2 | protein_coding | protein_coding | ENST00000376335 | 3 | 4993 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.974 | 0.0263 | 114911 | 0 | 96 | 115007 | 0.000417 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 3.21 | 98 | 237 | 0.413 | 0.0000112 | 3435 |
Missense in Polyphen | 29 | 91.104 | 0.31832 | 1286 | ||
Synonymous | -2.95 | 138 | 100 | 1.37 | 0.00000527 | 1072 |
Loss of Function | 3.10 | 0 | 11.2 | 0.00 | 4.87e-7 | 142 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.0121 | 0.00605 |
European (Non-Finnish) | 0.000377 | 0.000188 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00172 | 0.000857 |
dbNSFP
Source:
- Function
- FUNCTION: Acts as a transcriptional activator or repressor. Plays important roles in the early stage of organogenesis of the CNS. Activates the transcription of the serotonin transporter SERT in uncrossed ipsilateral retinal ganglion cells (iRGCs) to refine eye-specific projections in primary visual targets. Its transcriptional activity is repressed by MDFIC. Involved in the formation of the ipsilateral retinal projection at the optic chiasm midline. Drives the expression of EPHB1 on ipsilaterally projecting growth cones. Binds to the minimal GLI-consensus sequence 5'-TGGGTGGTC-3'. Associates to the basal SERT promoter region from ventrotemporal retinal segments of retinal embryos.;
- Disease
- DISEASE: Holoprosencephaly 5 (HPE5) [MIM:609637]: A structural anomaly of the brain, in which the developing forebrain fails to correctly separate into right and left hemispheres. Holoprosencephaly is genetically heterogeneous and associated with several distinct facies and phenotypic variability. {ECO:0000269|PubMed:11285244, ECO:0000269|PubMed:15221788, ECO:0000269|PubMed:15590697, ECO:0000269|PubMed:19177455, ECO:0000269|PubMed:9771712}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Mesodermal Commitment Pathway;Glucocorticoid Receptor Pathway;Nuclear Receptors Meta-Pathway
(Consensus)
Recessive Scores
- pRec
- 0.230
Haploinsufficiency Scores
- pHI
- 0.878
- hipred
- hipred_score
- ghis
- 0.627
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.815
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Zic2
- Phenotype
- vision/eye phenotype; digestive/alimentary phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); limbs/digits/tail phenotype; skeleton phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); embryo phenotype; pigmentation phenotype; growth/size/body region phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); normal phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); craniofacial phenotype; cellular phenotype;
Zebrafish Information Network
- Gene name
- zic2b
- Affected structure
- melanoblast
- Phenotype tag
- abnormal
- Phenotype quality
- aggregated
Gene ontology
- Biological process
- central nervous system development;brain development;visual perception;cell differentiation;negative regulation of transcription, DNA-templated;positive regulation of transcription, DNA-templated;positive regulation of transcription by RNA polymerase II;positive regulation of DNA-binding transcription factor activity
- Cellular component
- nucleus;cytoplasm;nuclear body
- Molecular function
- RNA polymerase II regulatory region sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;DNA binding;DNA-binding transcription factor activity;chromatin DNA binding;metal ion binding